Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body's main tools for slowing or stopping viral infections, yet research led by the universities of Cambridge and Glasgow shows that avian flu strains can keep multiplying even when the body reaches temperatures that normally hinder viruses.
In a study published in Science, the researchers identified a gene that strongly influences how sensitive a flu virus is to heat. During the major pandemics of 1957 and 1968, this gene moved into human flu viruses, and the resulting strains were able to spread efficiently.
Why Temperature Matters for Flu Viruses
Human flu viruses infect millions of people annually, with influenza A being the most common seasonal strain. These viruses replicate most effectively in the upper respiratory tract, where temperatures are around 33 °C. They replicate less efficiently deeper in the lungs, where temperatures rise to about 37 °C.
If left uncontrolled, viruses spread through the body and may cause severe illness. Fever is one of the body's protective responses and can raise core temperature to as high as 41 °C. Until recently, however, it remained unclear exactly how fever limits viral growth, or why some viruses can continue thriving despite it.
Avian Flu Thrives in Hotter Environments
Avian influenza viruses behave differently from human flu strains. They often grow in the lower respiratory tract, and in their usual hosts, including ducks and seagulls, they frequently infect the gut. These environments can reach temperatures of 40 to 42 °C.
Past laboratory studies using cultured cells showed that avian flu viruses tend to withstand temperatures similar to those seen during fever in humans. The new research turns to in vivo models, using mice infected with influenza viruses, to better understand how fever protects the body and why this protection may not be enough against bird flu.
Simulating Fever in Mice
The international team led by scientists in Cambridge and Glasgow created fever-like conditions in mice to observe how different flu strains responded. Their experiments used a laboratory-adapted human-origin influenza virus known as PR8, which is not a danger to humans.
Mice do not usually develop fever in response to influenza A viruses, so the team mimicked fever by raising the temperature of the environment where the mice lived (elevating the body temperature of the mice).
Human Flu Stops at High Heat, Avian Flu Does Not
The findings showed that increasing body temperature to fever levels effectively stopped human-origin flu viruses from replicating. This same temperature increase did not stop avian flu viruses. For human flu strains, raising the temperature by just 2 °C was enough to turn what would have been a lethal infection into a mild one.
A Key Gene Behind Bird Flu's Heat Resistance
The study also found that the PB1 gene, which supports viral genome replication inside infected cells, plays a major role in determining temperature sensitivity. Viruses with an avian-like PB1 gene tolerated fever-associated temperatures and caused severe illness in mice. This matters because human and bird flu viruses can exchange genes when they infect the same host, such as pigs, at the same time.
Dr. Matt Turnbull, first author of the study from the Medical Research Council Centre for Virus Research at the University of Glasgow, said: "The ability of viruses to swap genes is a continued source of threat for emerging flu viruses. We've seen it happen before during previous pandemics, such as in 1957 and 1968, where a human virus swapped its PB1 gene with that from an avian strain. This may help explain why these pandemics caused serious illness in people.
"It's crucial that we monitor bird flu strains to help us prepare for potential outbreaks. Testing potential spillover viruses for how resistant they are likely to be to fever may help us identify more virulent strains."
High Fatality Rates Highlight the Danger
Senior author Professor Sam Wilson, from the Cambridge Institute of Therapeutic Immunology and Infectious Disease at the University of Cambridge, said: "Thankfully, humans don't tend to get infected by bird flu viruses very frequently, but we still see dozens of human cases a year. Bird flu fatality rates in humans have traditionally been worryingly high, such as in historic H5N1 infections that caused more than 40% mortality.
"Understanding what makes bird flu viruses cause serious illness in humans is crucial for surveillance and pandemic preparedness efforts. This is especially important because of the pandemic threat posed by avian H5N1 viruses."
Implications for Treatment
Reference: "Avian-origin influenza A viruses tolerate elevated pyrexic temperatures in mammals" by Matthew L. Turnbull, Yingxue Wang, Simon Clare, Gauthier Lieber, Stephanie L. Williams, Marko Noerenberg, Akira J. T. Alexander, Sara Clohisey Hendry, Douglas G. Stewart, Joseph Hughes, Simon Swingler, Spyros Lytras, Emma L. Davies, Katherine Harcourt, Katherine Smollett, Rute M. Pinto, Hui-Min Lee, Eleanor R. Gaunt, Colin Loney, Johanna S. Jung, Paul A. Lyons, Darrell R. Kapczynski, Edward Hutchinson, Ana da Silva Filipe, Jeffery K. Taubenberger, Suzannah J. Rihn, J. Kenneth Baillie, Ervin Fodor, Alfredo Castello, Kenneth G. C. Smith, Paul Digard and Sam J. Wilson, 27 November 2025, Science.
DOI: 10.1126/science.adq4691
The research was funded primarily by the Medical Research Council, with additional funding from the Wellcome Trust, Biotechnology and Biological Sciences Research Council, European Research Council, European Union Horizon 2020, UK Department for Environment, Food & Rural Affairs, and US Department of Agriculture.
News
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]















